Nataliia Glushko
About
In The Last Decade
Nataliia Glushko
2 papers receiving 319 citations
Hit Papers
Peers
Comparison fields: 5 of 42
- Hematology 275
- Genetics 217
- Rheumatology 120
- Oncology 77
- Molecular Biology 42
Countries citing papers authored by Nataliia Glushko
This map shows the geographic impact of Nataliia Glushko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataliia Glushko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataliia Glushko more than expected).
Fields of papers citing papers by Nataliia Glushko
This network shows the impact of papers produced by Nataliia Glushko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataliia Glushko. The network helps show where Nataliia Glushko may publish in the future.
Co-authorship network of co-authors of Nataliia Glushko
This figure shows the co-authorship network connecting the top 25 collaborators of Nataliia Glushko. A scholar is included among the top collaborators of Nataliia Glushko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nataliia Glushko. Nataliia Glushko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial breakdown → | 320 |
| 2 | Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.